Tolar M, et al: Aducanumab, Gantenerumab, BAN2401, and ALZ-801the First Wave of Amyloid-Targeting Drugs for Alzheimer's Disease with Potential
Alzheon's valiltramiprosate/ALZ-801 is currently the only oral anti-amyloid treatment in Phase 3 testing for Alzheimer's disease.
ALZ-NET International partners meet quarterly to share updates and initiatives, including at an annual in-person meeting at the Alzheimer’s Association International Conference (AAIC). Collaboration between ALZ-NET International partners is encouraged through the formation of working groups to explore areas of mutual interest.
Ride to End ALZ training tips to help riders and their bikes go the distance. Our ride concierge can also help with a training plan right for each cyclist. To learn more about how you can connect with the Ride to End ALZ community and meet other riders, email .
Among the various new drugs that are being targeted for treatment are Donanemab, Lecanemab, and ALZ-801. Donanemab, an anti-amyloid antibody
Caregiver Corner: Have you heard of ALZ Connected? It's a free online community for everyone affected for Alzheimer's or other dementia. Including people
Alzheimer's drug, HT-ALZ. In a recent study using Alzheimer's model mice treated with varying doses of HT-ALZ, significant reductions in
ALZ-801 that is poised to become the first oral medication for Alzheimer's offers a more accessible treatment. This does not require any
When typing in this field, a list of search results will appear and be automatically updated as you type. Alzheimer's drug, HT-ALZ. In a
Comments